{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T01:42:14Z","timestamp":1744508534438,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005771","name":"Dokuz Eyl\u00fcl \u00dcniversitesi","doi-asserted-by":"publisher","award":["2021.KB.SAG.058","2021.KB.SAG.058","2021.KB.SAG.058","2021.KB.SAG.058","2021.KB.SAG.058"],"award-info":[{"award-number":["2021.KB.SAG.058","2021.KB.SAG.058","2021.KB.SAG.058","2021.KB.SAG.058","2021.KB.SAG.058"]}],"id":[{"id":"10.13039\/501100005771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02336-2","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T10:02:03Z","timestamp":1712656923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line"],"prefix":"10.1007","volume":"41","author":[{"given":"Nazli","family":"Demirkiran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengusu","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ogun","family":"Sercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"issue":"1","key":"2336_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1741-7015-9-99","volume":"9","author":"AM Eiring","year":"2011","unstructured":"Eiring AM, Khorashad JS, Morley K, Deininger MW. Advances in the treatment of chronic myeloid leukemia. BMC Med. 2011;9(1):99. https:\/\/doi.org\/10.1186\/1741-7015-9-99.","journal-title":"BMC Med"},{"issue":"10","key":"2336_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMOA1609324","volume":"376","author":"A Hochhaus","year":"2017","unstructured":"Hochhaus A, et al. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. N Engl J Med. 2017;376(10):917\u201327. https:\/\/doi.org\/10.1056\/NEJMOA1609324.","journal-title":"N Engl J Med"},{"key":"2336_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.146","author":"R Nusse","year":"2012","unstructured":"Nusse R, Varmus H. Focus review three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 2012. https:\/\/doi.org\/10.1038\/emboj.2012.146.","journal-title":"EMBO J"},{"issue":"6","key":"2336_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/J.CELL.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985\u201399. https:\/\/doi.org\/10.1016\/J.CELL.2017.05.016.","journal-title":"Cell"},{"issue":"14","key":"2336_CR5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMRA2304431","volume":"389","author":"CHM Jamieson","year":"2023","unstructured":"Jamieson CHM, Weissman IL. Stem-cell aging and pathways to precancer evolution. N Engl J Med. 2023;389(14):1310\u20139. https:\/\/doi.org\/10.1056\/NEJMRA2304431.","journal-title":"N Engl J Med"},{"key":"2336_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A015081","author":"CM Cruciat","year":"2013","unstructured":"Cruciat CM, Niehrs C. Secreted and Transmembrane Wnt Inhibitors and Activators. Cold Spring Harb Perspect Biol. 2013. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A015081.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"Pt 6","key":"2336_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1242\/JCS.026096","volume":"121","author":"P Bovolenta","year":"2008","unstructured":"Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci. 2008;121(Pt 6):737\u201346. https:\/\/doi.org\/10.1242\/JCS.026096.","journal-title":"J Cell Sci"},{"issue":"12\u201313","key":"2336_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1134\/S0006297918120039\/METRICS","volume":"83","author":"TI Fetisov","year":"2018","unstructured":"Fetisov TI, Lesovaya EA, Yakubovskaya MG, Kirsanov KI, Belitsky GA. Alterations in WNT signaling in leukemias. Biochem Mosc. 2018;83(12\u201313):1448\u201358. https:\/\/doi.org\/10.1134\/S0006297918120039\/METRICS.","journal-title":"Biochem Mosc"},{"issue":"5","key":"2336_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/J.EXER.2010.05.003","volume":"91","author":"W Mao","year":"2010","unstructured":"Mao W, Wordinger RJ, Clark AF. Focus on molecules: SFRP1. Exp Eye Res. 2010;91(5):552\u20133. https:\/\/doi.org\/10.1016\/J.EXER.2010.05.003.","journal-title":"Exp Eye Res"},{"issue":"5","key":"2336_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4161\/EPI.19614","volume":"7","author":"F Atschekzei","year":"2012","unstructured":"Atschekzei F, et al. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence. Epigenetics. 2012;7(5):447\u201357. https:\/\/doi.org\/10.4161\/EPI.19614.","journal-title":"Epigenetics"},{"key":"2336_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/S13148-019-0709-Y","author":"N Hattori","year":"2019","unstructured":"Hattori N, et al. Novel prodrugs of decitabine with greater metabolic stability and less toxicity. Clin Epigenetics. 2019. https:\/\/doi.org\/10.1186\/S13148-019-0709-Y.","journal-title":"Clin Epigenetics"},{"key":"2336_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAGEN.2012.08.010","author":"SJ K\u00fchl","year":"2013","unstructured":"K\u00fchl SJ, K\u00fchl M. On the role of Wnt\/\u03b2-catenin signaling in stem cells. Biochimica et Biophys Acta (BBA)\u2014General Sub. 2013. https:\/\/doi.org\/10.1016\/J.BBAGEN.2012.08.010.","journal-title":"Biochimica et Biophys Acta (BBA)\u2014General Sub"},{"key":"2336_CR13","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1200\/JCO.2005.01.4944","volume":"23","author":"J Roman-Gomez","year":"2005","unstructured":"Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. Lack of CpG Island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol. 2005;23:7043\u20139. https:\/\/doi.org\/10.1200\/JCO.2005.01.4944.","journal-title":"J Clin Oncol"},{"key":"2336_CR14","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.1074\/jbc.M609096200","volume":"282","author":"X Zhong","year":"2007","unstructured":"Zhong X, et al. Regulation of secreted frizzled-related protein-1 by heparin *. J Biol Chem. 2007;282:20523\u201333. https:\/\/doi.org\/10.1074\/jbc.M609096200.","journal-title":"J Biol Chem"},{"issue":"8","key":"2336_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/J.LEUKRES.2008.11.013","volume":"33","author":"M Pehlivan","year":"2009","unstructured":"Pehlivan M, Sercan Z, Sercan HO. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia. Leuk Res. 2009;33(8):1062\u20137. https:\/\/doi.org\/10.1016\/J.LEUKRES.2008.11.013.","journal-title":"Leuk Res"},{"key":"2336_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317701654\/FORMAT\/EPUB","author":"M Pehlivan","year":"2017","unstructured":"Pehlivan M, Caliskan C, Yuce Z, Sercan HO. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors. Tumor Biol. 2017. https:\/\/doi.org\/10.1177\/1010428317701654\/FORMAT\/EPUB.","journal-title":"Tumor Biol"},{"issue":"35","key":"2336_CR17","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/SJ.ONC.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK. 5-Azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002;21(35):5483\u201395. https:\/\/doi.org\/10.1038\/SJ.ONC.1205699.","journal-title":"Oncogene"},{"key":"2336_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.112","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and \u0131ts basic function. Neuropsychopharmacology. 2013. https:\/\/doi.org\/10.1038\/npp.2012.112.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2336_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrc3895","volume":"15","author":"L Yang","year":"2015","unstructured":"Yang L, Rau R, Goodell MA. DNMT3A in haematological malignancies. Nat Rev Cancer. 2015;15(3):152\u201365. https:\/\/doi.org\/10.1038\/nrc3895.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2336_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1523\/JNEUROSCI.1821-20.2020","volume":"41","author":"CB Greer","year":"2021","unstructured":"Greer CB, et al. Tet1 isoforms differentially regulate gene expression, synaptic transmission, and memory in the mammalian brain. J Neurosci. 2021;41(4):578. https:\/\/doi.org\/10.1523\/JNEUROSCI.1821-20.2020.","journal-title":"J Neurosci"},{"key":"2336_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.1210597","author":"S Ito","year":"2011","unstructured":"Ito S, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011. https:\/\/doi.org\/10.1126\/science.1210597.","journal-title":"Science"},{"issue":"8","key":"2336_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.18632\/ONCOTARGET.316","volume":"2","author":"MC Haffner","year":"2011","unstructured":"Haffner MC, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human cancers. Oncotarget. 2011;2(8):627\u201337. https:\/\/doi.org\/10.18632\/ONCOTARGET.316.","journal-title":"Oncotarget"},{"issue":"5858","key":"2336_CR23","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1126\/SCIENCE.1149460","volume":"318","author":"S Vasudevan","year":"2007","unstructured":"Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318(5858):1931\u20134. https:\/\/doi.org\/10.1126\/SCIENCE.1149460.","journal-title":"Science"},{"key":"2336_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/JCP.27486","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019. https:\/\/doi.org\/10.1002\/JCP.27486.","journal-title":"J Cell Physiol"},{"key":"2336_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-41","author":"K Machov\u00e1 Polakov\u00e1","year":"2011","unstructured":"Machov\u00e1 Polakov\u00e1 K, et al. Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol Cancer. 2011. https:\/\/doi.org\/10.1186\/1476-4598-10-41.","journal-title":"Mol Cancer"},{"key":"2336_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/S11658-020-00210-3","author":"N Sun","year":"2020","unstructured":"Sun N, Zhang L, Zhang C, Yuan Y. miR-144\u20133p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt\/\u03b2-catenin signaling. Cell Mol Biol Lett. 2020. https:\/\/doi.org\/10.1186\/S11658-020-00210-3.","journal-title":"Cell Mol Biol Lett"},{"key":"2336_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/J.OMTN.2019.12.017","volume":"19","author":"N Li","year":"2020","unstructured":"Li N, Liu L, Liu Y, Luo S, Song Y, Fang B. miR-144-3p suppresses osteogenic differentiation of bmscs from patients with aplastic anemia through repression of TET2. Mol Ther Nucleic Acids. 2020;19:619\u201326. https:\/\/doi.org\/10.1016\/J.OMTN.2019.12.017.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"2336_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMOA040258\/SUPPL_FILE\/657SA1.PDF","volume":"351","author":"CHM Jamieson","year":"2004","unstructured":"Jamieson CHM, et al. Granulocyte\u2013macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657\u201367. https:\/\/doi.org\/10.1056\/NEJMOA040258\/SUPPL_FILE\/657SA1.PDF.","journal-title":"N Engl J Med"},{"key":"2336_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2013.11.004","author":"R Surana","year":"2013","unstructured":"Surana R, et al. Secreted frizzled related proteins: Implications in cancers. Biochimica et Biophys Acta-Rev on Cancer. 2013. https:\/\/doi.org\/10.1016\/j.bbcan.2013.11.004.","journal-title":"Biochimica et Biophys Acta-Rev on Cancer"},{"issue":"1","key":"2336_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<95::AID-IJC15>3.0.CO;2-4","volume":"78","author":"Z Zhou","year":"1998","unstructured":"Zhou Z, Wang J, Han X, Zhou J, Linder S. Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer. 1998;78(1):95\u20139. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19980925)78:1%3c95::AID-IJC15%3e3.0.CO;2-4.","journal-title":"Int J Cancer"},{"key":"2336_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/path.1035","author":"SC Wong","year":"2002","unstructured":"Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol. 2002. https:\/\/doi.org\/10.1002\/path.1035.","journal-title":"J Pathol"},{"issue":"2","key":"2336_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng892","volume":"31","author":"H Suzuki","year":"2002","unstructured":"Suzuki H, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 2002;31(2):141\u20139. https:\/\/doi.org\/10.1038\/ng892.","journal-title":"Nat Genet"},{"key":"2336_CR33","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.83709","author":"C Ma","year":"2019","unstructured":"Ma C, et al. Cytosine Modifications and Distinct Functions of TET1 on Tumorigenesis. Chromatin and Epigenetics. 2019. https:\/\/doi.org\/10.5772\/INTECHOPEN.83709.","journal-title":"Chromatin and Epigenetics"},{"issue":"17","key":"2336_CR34","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1182\/BLOOD-2011-08-373357","volume":"118","author":"M Ko","year":"2011","unstructured":"Ko M, Rao A. TET2: epigenetic safeguard for HSC. Blood. 2011;118(17):4501\u20133. https:\/\/doi.org\/10.1182\/BLOOD-2011-08-373357.","journal-title":"Blood"},{"key":"2336_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/gad.276568.115","author":"KD Rasmussen","year":"2016","unstructured":"Rasmussen KD, Helin K. Role of TET enzymes in DNA methylation, development, and cancer. Genes and Development. 2016. https:\/\/doi.org\/10.1101\/gad.276568.115.","journal-title":"Genes and Development"},{"issue":"7447","key":"2336_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/NATURE12052","volume":"497","author":"M Ko","year":"2013","unstructured":"Ko M, et al. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature. 2013;497(7447):122\u20136. https:\/\/doi.org\/10.1038\/NATURE12052.","journal-title":"Nature"},{"issue":"1","key":"2336_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/IMR.12239","volume":"263","author":"M Ko","year":"2015","unstructured":"Ko M, An J, Pastor WA, Koralov SB, Rajewsky K, Rao A. TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunol Rev. 2015;263(1):6\u201321. https:\/\/doi.org\/10.1111\/IMR.12239.","journal-title":"Immunol Rev"},{"issue":"9","key":"2336_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/J.LEUKRES.2014.07.002","volume":"38","author":"S Li","year":"2014","unstructured":"Li S, Fan R, Zhao XL, Wang XQ. CXXC4 mRNA levels are associated with clinicopathological parameters and survival of myelodysplastic syndrome patients. Leuk Res. 2014;38(9):1072\u20138. https:\/\/doi.org\/10.1016\/J.LEUKRES.2014.07.002.","journal-title":"Leuk Res"},{"issue":"2","key":"2336_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ONC.2008.391","volume":"28","author":"T Kojima","year":"2009","unstructured":"Kojima T, et al. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling. Oncogene. 2009;28(2):297\u2013305. https:\/\/doi.org\/10.1038\/ONC.2008.391.","journal-title":"Oncogene"},{"issue":"8","key":"2336_CR40","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/JCB.24154","volume":"113","author":"M Mancini","year":"2012","unstructured":"Mancini M, et al. Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia. J Cell Biochem. 2012;113(8):2765\u201374. https:\/\/doi.org\/10.1002\/JCB.24154.","journal-title":"J Cell Biochem"},{"issue":"8","key":"2336_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4161\/EPI.29628","volume":"9","author":"A Loriot","year":"2014","unstructured":"Loriot A, et al. A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors. Epigenetics. 2014;9(8):1163. https:\/\/doi.org\/10.4161\/EPI.29628.","journal-title":"Epigenetics"},{"key":"2336_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/J.OMTN.2020.05.033","volume":"22","author":"M Jia","year":"2020","unstructured":"Jia M, Li Z, Pan M, Tao M, Wang J, Lu X. LINC-PINT suppresses the aggressiveness of thyroid cancer by downregulating miR-767-5p to induce TET2 expression. Mol Ther Nucleic Acids. 2020;22:319\u201328. https:\/\/doi.org\/10.1016\/J.OMTN.2020.05.033.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"2336_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/890","volume":"19","author":"M Okano","year":"1998","unstructured":"Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 1998;19(3):219\u201320. https:\/\/doi.org\/10.1038\/890.","journal-title":"Nat Genet"},{"key":"2336_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7926483","author":"J Yu","year":"2022","unstructured":"Yu J, et al. miR-26a-5p suppresses Wnt\/ \u03b2-catenin signaling pathway by \u0131nhibiting DNMT3A-mediated SFRP1 methylation and \u0131nhibits cancer stem cell-like properties of NSCLC. Dis Markers. 2022. https:\/\/doi.org\/10.1155\/2022\/7926483.","journal-title":"Dis Markers"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02336-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02336-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02336-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T05:17:04Z","timestamp":1717046224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02336-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02336-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Dokuz Eylul University (2020\/29\u201322).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"109"}}